195
Views
21
CrossRef citations to date
0
Altmetric
Systematic Review

Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials

, &
Pages 91-97 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Federica Dall’Oglio, Maria Rita Nasca, Carlo Gerbino & Giuseppe Micali. (2022) An Overview of the Diagnosis and Management of Seborrheic Dermatitis. Clinical, Cosmetic and Investigational Dermatology 15, pages 1537-1548.
Read now
Luis J. Borda, Marina Perper & Jonette E. Keri. (2019) Treatment of seborrheic dermatitis: a comprehensive review. Journal of Dermatological Treatment 30:2, pages 158-169.
Read now
C. S. L. Kamamoto, A. S. Nishikaku, O. F. Gompertz, A. S. Melo, K. M. Hassun & E. Bagatin. (2017) Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial. Dermato-Endocrinology 9:1.
Read now

Articles from other publishers (18)

Márcia S. Zampese, Gabriela Czarnobay Garbin, Lucas Samuel Perinazzo Pauvels & Luciana Pavan Antonioli. 2023. Dermatology in Public Health Environments. Dermatology in Public Health Environments 1169 1258 .
Odeh Alsmeirat, Som Lakhani, Musab Egaimi, Osama Idris & Mohamed Elkhalifa. (2022) The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials. Cureus.
Crossref
Z Nemeth, E Verga & R Verdolini. (2022) Topical treatment of eczematous external otitis involving the ear canal: long-term results of a trial comparing pimecrolimus 1 per cent versus clobetasone butyrate 0.05 per cent. The Journal of Laryngology & Otology 136:7, pages 635-638.
Crossref
Rashmi SinghBhushan MadkeShiti Bose. (2022) Seborrheic dermatitis and pityriasis sicca: A review. CosmoDerma 2, pages 36.
Crossref
E. M. Markelova. (2021) Management of patients with seborrheic dermatitis. Medical alphabet:27, pages 56-60.
Crossref
Vincent Michael Imbrogno. 2021. Blepharitis. Blepharitis 23 43 .
Ditte M. L. Saunte, George Gaitanis & Roderick James Hay. (2020) Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment. Frontiers in Cellular and Infection Microbiology 10.
Crossref
A.S. Polonskaya, E.A. Shatokhina & L.S. Kruglova. (2020) Seborrheic dermatitis: current ideas of the etiology, pathogenesis, and treatment approaches. Klinicheskaya dermatologiya i venerologiya 19:4, pages 451.
Crossref
Lyn Guenther, Charles Lynde & Yves Poulin. (2019) Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic Disorders. Journal of Cutaneous Medicine and Surgery 23:4_suppl, pages 27S-34S.
Crossref
G. Quéreux. (2019) Dermatitis seborreica. EMC - Dermatología 53:1, pages 1-9.
Crossref
Juemin Zhao, Wenjia Sun, Chengfeng Zhang, Jiaqiang Wu, Yan Le, Chunyun Huang, Ye Liu & Leihong Xiang. (2018) Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis. Journal of Cosmetic Dermatology 17:1, pages 90-94.
Crossref
Márcia S. Zampese, Gabriela Czarnobay Garbin & Bruna Guerra Rech. 2018. Dermatology in Public Health Environments. Dermatology in Public Health Environments 835 918 .
Helena Kastarinen, Tuija Oksanen, Enembe O Okokon, Vesa V Kiviniemi, Kristiina Airola, Johanna Jyrkkä, Tuomas Oravilahti, Piia K Rannanheimo & Jos H Verbeek. (2014) Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp. Cochrane Database of Systematic Reviews 2017:8.
Crossref
M. Goldust, E. Rezaee & R. Raghifar. (2013) Treatment of seborrheic dermatitis: comparison of sertaconazole 2 % cream versus pimecrolimus 1 % cream. Irish Journal of Medical Science 182:4, pages 703-706.
Crossref
Clio Dessinioti & Andreas Katsambas. (2013) Seborrheic dermatitis: Etiology, risk factors, and treatments:. Clinics in Dermatology 31:4, pages 343-351.
Crossref
Hamideh Azimi, Farideh Golforoushan, Mahnaz Jaberian, Shhla Talghini & Mohamad Goldust. (2013) Efficiency of terbinafine 1% cream in comparison with ketoconazole 2% cream and placebo in patients with facial seborrheic dermatitis. Journal of Dermatological Treatment, pages 1-3.
Crossref
Mohamad Goldust, Mohamad Reza Ranjkesh, Mehdi Amirinia, Farideh Golforoushan, Elham Rezaee & Mohammad Amin Rezazadeh Saatlou. (2013) Sertaconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. Journal of Dermatological Treatment, pages 1-3.
Crossref
Jonas T. Schnider, Matthias Weinstock, Jan A. Plock, Mario G. Solari, Raman Venkataramanan, Xin Xiao Zheng & Vijay S. Gorantla. (2013) Site-Specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential. Clinical and Developmental Immunology 2013, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.